With its three investigational new drugs for depression (BLI-1005), for inflammatory bowel disease (BLI-1006),

and for myelodysplastic syndrome (BLI-1301), BioLite, Inc. was one of the leading companies which won the

2015 Annual Innovation Award.

The Annual Innovation Award is held every two years by Outstanding Enterprise Manager Association

(OEMA) in Taiwan to encourage excellent enterprises and professional leaders.